These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35114463)

  • 1. Development of a DNA aptamer that binds to the complementarity-determining region of therapeutic monoclonal antibody and affinity improvement induced by pH-change for sensitive detection.
    Saito T; Shimizu Y; Tsukakoshi K; Abe K; Lee J; Ueno K; Asano R; Jones BV; Yamada T; Nakano T; Tong J; Hishiki A; Hara K; Hashimoto H; Sode K; Toyo'oka T; Todoroki K; Ikebukuro K
    Biosens Bioelectron; 2022 May; 203():114027. PubMed ID: 35114463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an Anti-Idiotype Aptamer-Based Electrochemical Sensor for a Humanized Therapeutic Antibody Monitoring.
    Nagata M; Lee J; Saito T; Ikebukuro K; Sode K
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginine mutations in antibody complementarity-determining regions display context-dependent affinity/specificity trade-offs.
    Tiller KE; Li L; Kumar S; Julian MC; Garde S; Tessier PM
    J Biol Chem; 2017 Oct; 292(40):16638-16652. PubMed ID: 28778924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular affinity rulers: systematic evaluation of DNA aptamers for their applicabilities in ELISA.
    Kimoto M; Shermane Lim YW; Hirao I
    Nucleic Acids Res; 2019 Sep; 47(16):8362-8374. PubMed ID: 31392985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly sensitive antibody-aptamer sensor for vascular endothelial growth factor based on hybridization chain reaction and pH meter/indicator.
    Xu H; Kou F; Ye H; Wang Z; Huang S; Liu X; Zhu X; Lin Z; Chen G
    Talanta; 2017 Dec; 175():177-182. PubMed ID: 28841975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balancing charge in the complementarity-determining regions of humanized mAbs without affecting pI reduces non-specific binding and improves the pharmacokinetics.
    Datta-Mannan A; Thangaraju A; Leung D; Tang Y; Witcher DR; Lu J; Wroblewski VJ
    MAbs; 2015; 7(3):483-93. PubMed ID: 25695748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alkaline-tolerant RNA aptamers useful to purify acid-sensitive antibodies in neutral conditions.
    Inomata E; Tashiro E; Miyakawa S; Nakamura Y; Akita K
    Biochimie; 2018 Feb; 145():113-124. PubMed ID: 29104137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Throughput Bioanalysis of Bevacizumab in Human Plasma Based on Enzyme-Linked Aptamer Assay Using Anti-Idiotype DNA Aptamer.
    Yamada T; Saito T; Hill Y; Shimizu Y; Tsukakoshi K; Mizuno H; Hayashi H; Ikebukuro K; Toyo'oka T; Todoroki K
    Anal Chem; 2019 Feb; 91(4):3125-3130. PubMed ID: 30667211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple and fast one-step FRET assay of therapeutic mAb bevacizumab using anti-idiotype DNA aptamer for process analytical technology.
    Yamada T; Tsukakoshi K; Furusho A; Sugiyama E; Mizuno H; Hayashi H; Yamano T; Kumobayashi H; Hasebe T; Ikebukuro K; Toyo'oka T; Todoroki K
    Talanta; 2024 Sep; 277():126349. PubMed ID: 38852342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions.
    Finlay WJ; Cunningham O; Lambert MA; Darmanin-Sheehan A; Liu X; Fennell BJ; Mahon CM; Cummins E; Wade JM; O'Sullivan CM; Tan XY; Piche N; Pittman DD; Paulsen J; Tchistiakova L; Kodangattil S; Gill D; Hufton SE
    J Mol Biol; 2009 May; 388(3):541-58. PubMed ID: 19285987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain.
    Almagro JC; Raghunathan G; Beil E; Janecki DJ; Chen Q; Dinh T; LaCombe A; Connor J; Ware M; Kim PH; Swanson RV; Fransson J
    J Mol Recognit; 2012 Mar; 25(3):125-35. PubMed ID: 22407976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
    Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
    Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal charged mutations in the complementarity-determining regions that prevent domain antibody aggregation are dependent on the antibody scaffold.
    Perchiacca JM; Lee CC; Tessier PM
    Protein Eng Des Sel; 2014 Feb; 27(2):29-39. PubMed ID: 24398633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Idiotype DNA Aptamer Affinity Purification⁻High-Temperature Reversed-Phase Liquid Chromatography: A Simple, Accurate, and Selective Bioanalysis of Bevacizumab.
    Yamada T; Saito T; Shimizu Y; Tsukakoshi K; Hayashi H; Mizuno H; Tsuji D; Yamamoto K; Itoh K; Toyo'oka T; Ikebukuro K; Todoroki K
    Molecules; 2019 Feb; 24(5):. PubMed ID: 30823418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chain.
    Yan B; Steen S; Hambly D; Valliere-Douglass J; Vanden Bos T; Smallwood S; Yates Z; Arroll T; Han Y; Gadgil H; Latypov RF; Wallace A; Lim A; Kleemann GR; Wang W; Balland A
    J Pharm Sci; 2009 Oct; 98(10):3509-21. PubMed ID: 19475547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grafting of "abbreviated" complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody.
    De Pascalis R; Iwahashi M; Tamura M; Padlan EA; Gonzales NR; Santos AD; Giuliano M; Schuck P; Schlom J; Kashmiri SV
    J Immunol; 2002 Sep; 169(6):3076-84. PubMed ID: 12218124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downsizing antibodies: Towards complementarity-determining region (CDR)-based peptide mimetics.
    Van Holsbeeck K; Martins JC; Ballet S
    Bioorg Chem; 2022 Feb; 119():105563. PubMed ID: 34942468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High affinity truncated DNA aptamers for the development of fluorescence based progesterone biosensors.
    Alhadrami HA; Chinnappan R; Eissa S; Rahamn AA; Zourob M
    Anal Biochem; 2017 May; 525():78-84. PubMed ID: 28237255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro selection of DNA aptamers targeting β-lactoglobulin and their integration in graphene-based biosensor for the detection of milk allergen.
    Eissa S; Zourob M
    Biosens Bioelectron; 2017 May; 91():169-174. PubMed ID: 28006685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A label-free electrochemical biosensor based on a DNA aptamer against codeine.
    Huang L; Yang X; Qi C; Niu X; Zhao C; Zhao X; Shangguan D; Yang Y
    Anal Chim Acta; 2013 Jul; 787():203-10. PubMed ID: 23830440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.